[AVEO] AVEO Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.6 Change: 0.02 (3.69%)
Ext. hours: Change: 0 (0%)

chart AVEO

Refresh chart

Description: AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. Its therapeutic candidates under development program include AV-203, an anti-ErbB3 monoclonal antibody that has completed a Phase 1 dose escalation study; Ficlatuzumab, a hepatocyte growth factor inhibitory antibody, which is in Phase 2 trial; Tivozanib, an investigational tyrosine kinase inhibitor of various vascular endothelial growth factor receptors; and AV-380 Program, a program focusing on cachexia, a serious and common complication of advanced cancer, as well as a range of chronic diseases that is characterized by unintentional weight loss, progressive muscle wasting, and a loss of appetite. AVEO Pharmaceuticals, Inc. has strategic partnerships with St. Vincent?s Hospital Sydney Limited; Kyowa Hakko Kirin; Biogen Idec, Inc.; OSI Pharmaceuticals, Inc.; Centocor Ortho Biotech Inc.; and Merck & Co.,

Fundamental Ratios
Shares Outstanding EPS-0.39 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -92.74% Sales Growth - Q/Q15.52% P/E-1.95
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-114.32% ROE-391.69% ROI-243.81%
Current Ratio1.67 Quick Ratio Long Term Debt/Equity0.46 Debt Ratio1.82
Gross Margin Operating Margin-1843.19% Net Profit Margin-1925.98% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.67 M Cash From Investing Activities-3.62 M Cash From Operating Activities-15.82 M Gross Profit
Net Profit-10.87 M Operating Profit-10.15 M Total Assets50 M Total Current Assets44.42 M
Total Current Liabilities26.55 M Total Debt18.02 M Total Liabilities35.41 M Total Revenue130 K
Technical Data
High 52 week3.48 Low 52 week0.59 Last close0.66 Last change5.76%
RSI54.47 Average true range0.05 Beta1.05 Volume244.22 K
Simple moving average 20 days-16.37% Simple moving average 50 days-53.57% Simple moving average 200 days-69.38%
Performance Data
Performance Week6.92% Performance Month-61.79% Performance Quart-66.95% Performance Half-72.11%
Performance Year-76.89% Performance Year-to-date-58.69% Volatility daily20.49% Volatility weekly45.82%
Volatility monthly93.91% Volatility yearly325.31% Relative Volume297.41% Average Volume3.32 M
New High New Low

News

2019-08-09 11:29:03 | AVEO Pharmaceuticals AVEO Q2 Earnings Beat, Revenues Lag

2019-08-08 08:35:12 | AVEO Pharmaceuticals AVEO Reports Q2 Loss, Misses Revenue Estimates

2019-08-08 07:00:00 | AVEO Reports Second Quarter 2019 Financial Results and Provides Business Update

2019-07-30 10:38:02 | AVEO Pharmaceuticals AVEO May Report Negative Earnings: Know the Trend Ahead of Q2 Release

2019-07-08 17:05:09 | AVEO Pharmaceuticals Down More Than 50% YTD: Here's Why

2019-07-03 08:40:12 | Implied Volatility Surging for AVEO Pharmaceuticals AVEO Stock Options

2019-06-08 09:30:01 | AVEO AVEO Down 19.9% Since Last Earnings Report: Can It Rebound?

2019-05-29 07:00:00 | AVEO Oncology to Present at the 2019 BIO International Convention

2019-05-22 10:26:02 | Implied Volatility Surging for AVEO Pharmaceuticals AVEO Stock Options

2019-05-15 17:00:00 | AVEO Oncology Announces Presentations at the 2019 ASCO Annual Meeting

2019-05-11 02:51:06 | AVEO Pharmaceuticals AVEO Q1 Earnings & Revenues Miss Mark

2019-05-10 15:29:07 | AVEO Pharmaceuticals AVEO Q1 Earnings & Revenues Miss Mark

2019-05-09 08:25:12 | AVEO Pharmaceuticals AVEO Reports Q1 Loss, Tops Revenue Estimates

2019-05-09 07:18:33 | AVEO: 1Q Earnings Snapshot

2019-05-09 07:00:00 | AVEO Reports First Quarter 2019 Financial Results and Provides Business Update

2019-05-07 10:30:02 | AVEO Pharmaceuticals AVEO May Report Negative Earnings: Know the Trend Ahead of Q1 Release

2019-05-01 17:45:09 | AVEO Pharmaceuticals AVEO Dips More Than Broader Markets: What You Should Know

2019-05-01 07:00:00 | AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit

2019-04-30 11:39:03 | AVEO Pharmaceuticals AVEO to Post Q1 Earnings: What's Up?

2019-04-26 08:30:00 | FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-25 21:09:00 | APRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. AVEO and Encourages AVEO Investors Who Suffered Losses Exceeding $100,000 to Contact the Firm

2019-04-25 17:30:00 | CLASS ACTION UPDATE for AVEO, AAPL and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-25 15:50:00 | FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-25 10:57:44 | CLASS ACTION UPDATE for CORT, AVEO, NIO and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-25 10:15:00 | Final Deadline DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-25 09:00:00 | FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-24 17:45:09 | AVEO Pharmaceuticals AVEO Dips More Than Broader Markets: What You Should Know

2019-04-24 16:45:00 | CLASS ACTION UPDATE for AVEO, KHC and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-24 15:50:00 | FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-24 12:40:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, INGN and NTNX

2019-04-23 18:50:00 | APRIL 26 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-23 18:30:00 | CLASS ACTION UPDATE for AVEO, DPLO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-23 18:28:45 | AVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important April 26th Deadline in Securities Class Action Lawsuit – AVEO

2019-04-23 16:25:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – AVEO

2019-04-23 16:05:00 | AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain

2019-04-23 15:45:00 | SHAREHOLDER ALERT: AVEO BA S: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-04-23 15:00:00 | Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-23 11:17:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO and EB

2019-04-23 10:14:00 | Final Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

2019-04-19 18:25:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, SYNH and INGN

2019-04-19 17:55:00 | FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-19 10:39:37 | SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-04-18 15:17:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AVEO

2019-04-18 14:50:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, CTL and WSR

2019-04-18 14:02:31 | APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEO

2019-04-18 13:40:00 | IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-18 10:11:46 | CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-04-18 09:38:01 | AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why

2019-04-18 08:39:12 | Will AVEO Pharmaceuticals Continue to Surge Higher?

2019-04-17 18:45:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, AMRN and CVS